Br J Surg. 2020 Jul;107(8):1023-1032. doi: 10.1002/bjs.11453. Epub 2020 Feb 5.
This study aimed to determine the impact of preoperative exposure to intravenous contrast for CT and the risk of developing postoperative acute kidney injury (AKI) in patients undergoing major gastrointestinal surgery.
This prospective, multicentre cohort study included adults undergoing gastrointestinal resection, stoma reversal or liver resection. Both elective and emergency procedures were included. Preoperative exposure to intravenous contrast was defined as exposure to contrast administered for the purposes of CT up to 7 days before surgery. The primary endpoint was the rate of AKI within 7 days. Propensity score-matched models were adjusted for patient, disease and operative variables. In a sensitivity analysis, a propensity score-matched model explored the association between preoperative exposure to contrast and AKI in the first 48 h after surgery.
A total of 5378 patients were included across 173 centres. Overall, 1249 patients (23·2 per cent) received intravenous contrast. The overall rate of AKI within 7 days of surgery was 13·4 per cent (718 of 5378). In the propensity score-matched model, preoperative exposure to contrast was not associated with AKI within 7 days (odds ratio (OR) 0·95, 95 per cent c.i. 0·73 to 1·21; P = 0·669). The sensitivity analysis showed no association between preoperative contrast administration and AKI within 48 h after operation (OR 1·09, 0·84 to 1·41; P = 0·498).
There was no association between preoperative intravenous contrast administered for CT up to 7 days before surgery and postoperative AKI. Risk of contrast-induced nephropathy should not be used as a reason to avoid contrast-enhanced CT.
本研究旨在确定接受重大胃肠手术的患者术前接受 CT 静脉造影对比剂暴露与术后急性肾损伤(AKI)风险之间的关系。
本前瞻性多中心队列研究纳入了接受胃肠切除、造口还纳或肝切除术的成年人。包括择期和急诊手术。术前静脉造影对比剂暴露定义为术前 7 天内为 CT 目的而接受的造影剂暴露。主要终点是术后 7 天内 AKI 的发生率。采用倾向评分匹配模型调整患者、疾病和手术变量。在敏感性分析中,采用倾向评分匹配模型探讨了术后 48 小时内术前暴露于对比剂与 AKI 之间的关联。
共有 173 个中心的 5378 名患者纳入研究。总体而言,1249 名患者(23.2%)接受了静脉造影。术后 7 天内 AKI 的总体发生率为 13.4%(5378 例中有 718 例)。在倾向评分匹配模型中,术前接受对比剂与术后 7 天内 AKI 无关(比值比(OR)0.95,95%置信区间(CI)0.73 至 1.21;P=0.669)。敏感性分析显示,术后 48 小时内术前给予对比剂与 AKI 之间无关联(OR 1.09,0.84 至 1.41;P=0.498)。
术前 7 天内接受 CT 静脉造影对比剂与术后 AKI 之间没有关联。不应该将对比剂诱导的肾病风险作为避免使用增强 CT 的理由。